MOLECULAR PARTNERS N/ CH0256379097 /
| 2024-04-30 5:31:59 PM | Chg. +0.1050 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 3.2900CHF | +3.30% | 7,037 Turnover: 22,927.6150 |
3.0600Bid Size: 100 | 3.3600Ask Size: 89 | 119.61 mill.CHF | - | - |
Assets
|
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 2.3000 | 2 | 2.5000 | 2.4000 | 1.9000 | ||||||
| Intangible Assets | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Fixed Assets | 2.3000 | 2.1000 | 2.5000 | 2.5000 | 1.9000 | ||||||
| Inventories | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Accounts Receivable | 10.9000 | 3.2000 | 1.3000 | .8000 | 1.1000 | ||||||
| Cash and Cash Equivalents | 96.1000 | 188.4000 | 195.4000 | 149.7000 | 131.3000 | ||||||
| Current Assets | 107.8000 | 192 | 216.9000 | 181.6000 | 142.5000 | ||||||
| Total Assets | 110.1000 | 194 | 219.4000 | 184.1000 | 144.4000 | ||||||
Liabilities
|
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.2000 | 1.1000 | 1.8000 | 1.4000 | 1.3000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Provisions | 3.7000 | 2.4000 | 2.5000 | 4 | 4 | ||||||
| Liabilities | 61.8000 | 45.5000 | 67.6000 | 42.7000 | 27.7000 | ||||||
| Share Capital | 1.5000 | 2 | 2 | 2.1000 | 2.1000 | ||||||
| Total Equity | 48.3000 | 148.5000 | 151.8000 | 141.4000 | 116.7000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 110.1000 | 194 | 219.4000 | 184.1000 | 144.4000 | ||||||
Income Statement
|
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 32.4000 | 26.6000 | 29.1000 | 23 | 20 | ||||||
| Depreciation (total) | .8000 | .8000 | .9000 | 1.1000 | 1.1000 | ||||||
| Operating Result | 7.1000 | 1.8000 | -2.2000 | -19.5000 | -25.8000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | 7.1000 | -2.3000 | -.1000 | -18.6000 | -25.4000 | ||||||
| Income Taxes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | 7.1000 | -2.3000 | -.1000 | -18.6000 | -25.4000 | ||||||
Per Share
Cash Flow
|
2013 IFRS in mill. CHF |
2014 IFRS in mill. CHF |
2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -13.6000 | -11.3000 | 26.5000 | -35.4000 | -40 | ||||||
| Cash Flow from Investing Activities | -1.2000 | -.2000 | -20.7000 | -11.3000 | -20.9000 | ||||||
| Cash Flow from Financing | -2 | 101.2000 | .2000 | .4000 | .8000 | ||||||
| Decrease / Increase in Cash | -17.1000 | 92.3000 | 7 | -45.6000 | -18.4000 | ||||||
| Employees | - | 74 | 89 | 103 | 108 | ||||||
